JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Humaira Zafar | |
| dc.date.accessioned | 2024-10-09T04:48:13Z | |
| dc.date.available | 2024-10-09T04:48:13Z | |
| dc.date.issued | 2020-05 | |
| dc.identifier.uri | 10.5455/JPMA.08 | |
| dc.identifier.uri | http://hdl.handle.net/123456789/18052 | |
| dc.description | Seniors Professor Dr. Humaira Zafar, BUCM, Department of Pathology | |
| dc.description.abstract | The end of 2019 marked the start of coronavirus disease (COVID-19) pandemic from China, which went on to envelope more than 190 countries and territories across the globe. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from a group of betacoronaviruses, is responsible for COVID-19. The virulent factors include the presence of envelope and spike proteins having receptor bonding domains (RBD). Clinical manifestations can range from mild respiratory infections to fatal outcomes. The viability of virus ranges from 3 to 72 hours. Polymerase chain reaction (PCR) is the diagnostic test of choice in this pandemic situation. Due to the absence of specific antivirals and vaccine, adoption of preventive option can help to combat the specific life-threatening outcomes. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Journal of the Pakistan Medical Association | en_US |
| dc.subject | Coronaviruses, SARS-CoV- 2, Respiratory Infections, Receptor Binding Domains, Angiotensin Converting Enzyme 2, Pandemic. | en_US |
| dc.title | The Microbiology of Coronaviruses | en_US |
| dc.type | Article | en_US |
